Infectious complications of percutaneous vascular closure devices

Muhammad R. Sohail, Akbar H. Khan, David Holmes, Walter R. Wilson, James M. Steckelberg, Larry M. Baddour

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

OBJECTIVE: To describe the infectious complications of percutaneous vascular closure devices (PVCDs) on the basis of our institutional experience with PVCDs and the published medical literature. PATIENTS AND METHODS: We retrospectively reviewed all cases of PVCD-related Infection seen at the Mayo Clinic in Rochester, Mlnn, between January 1, 2000, and December 31, 2003, and searched the English language medical literature for all previously published reports. RESULTS: We identified 46 cases in the medical literature and 6 cases from our institutional database. The median age of patients was 63 years (range, 40-79 years). Diabetes mellitus and obesity were the most common comorbidlties. The median incubation period from device insertion to presentation with access-site infection was 8 days (range, 2-29 days). The most common presenting symptoms were pain, erythema, fever, swelling, and purulent drainage at the access site. Mycotic pseudoaneurysm (22 cases) was the most common complication. Staphylococcus aureus was responsible for most (75%) of the Infections. All patients underwent surgical débrldement, and 54% required reconstructive procedures. The median duration of antibiotic treatment was 28 days (range, 7-42 days). The mortality rate was 6% (3 patients). CONCLUSIONS: Infection associated with PVCD placement is uncommon but is an extremely serious complication. Morbidity is high, and aggressive medical and surgical interventions are required to achieve cure.

Original languageEnglish (US)
Pages (from-to)1011-1015
Number of pages5
JournalMayo Clinic Proceedings
Volume80
Issue number8
StatePublished - 2005

Fingerprint

Infection
False Aneurysm
Erythema
Staphylococcus aureus
Drainage
Diabetes Mellitus
Fever
Language
Obesity
Databases
Anti-Bacterial Agents
Morbidity
Pain
Equipment and Supplies
Mortality
Vascular Closure Devices
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sohail, M. R., Khan, A. H., Holmes, D., Wilson, W. R., Steckelberg, J. M., & Baddour, L. M. (2005). Infectious complications of percutaneous vascular closure devices. Mayo Clinic Proceedings, 80(8), 1011-1015.

Infectious complications of percutaneous vascular closure devices. / Sohail, Muhammad R.; Khan, Akbar H.; Holmes, David; Wilson, Walter R.; Steckelberg, James M.; Baddour, Larry M.

In: Mayo Clinic Proceedings, Vol. 80, No. 8, 2005, p. 1011-1015.

Research output: Contribution to journalArticle

Sohail, MR, Khan, AH, Holmes, D, Wilson, WR, Steckelberg, JM & Baddour, LM 2005, 'Infectious complications of percutaneous vascular closure devices', Mayo Clinic Proceedings, vol. 80, no. 8, pp. 1011-1015.
Sohail MR, Khan AH, Holmes D, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clinic Proceedings. 2005;80(8):1011-1015.
Sohail, Muhammad R. ; Khan, Akbar H. ; Holmes, David ; Wilson, Walter R. ; Steckelberg, James M. ; Baddour, Larry M. / Infectious complications of percutaneous vascular closure devices. In: Mayo Clinic Proceedings. 2005 ; Vol. 80, No. 8. pp. 1011-1015.
@article{90774c112d984330bab851b329e0dc56,
title = "Infectious complications of percutaneous vascular closure devices",
abstract = "OBJECTIVE: To describe the infectious complications of percutaneous vascular closure devices (PVCDs) on the basis of our institutional experience with PVCDs and the published medical literature. PATIENTS AND METHODS: We retrospectively reviewed all cases of PVCD-related Infection seen at the Mayo Clinic in Rochester, Mlnn, between January 1, 2000, and December 31, 2003, and searched the English language medical literature for all previously published reports. RESULTS: We identified 46 cases in the medical literature and 6 cases from our institutional database. The median age of patients was 63 years (range, 40-79 years). Diabetes mellitus and obesity were the most common comorbidlties. The median incubation period from device insertion to presentation with access-site infection was 8 days (range, 2-29 days). The most common presenting symptoms were pain, erythema, fever, swelling, and purulent drainage at the access site. Mycotic pseudoaneurysm (22 cases) was the most common complication. Staphylococcus aureus was responsible for most (75{\%}) of the Infections. All patients underwent surgical d{\'e}brldement, and 54{\%} required reconstructive procedures. The median duration of antibiotic treatment was 28 days (range, 7-42 days). The mortality rate was 6{\%} (3 patients). CONCLUSIONS: Infection associated with PVCD placement is uncommon but is an extremely serious complication. Morbidity is high, and aggressive medical and surgical interventions are required to achieve cure.",
author = "Sohail, {Muhammad R.} and Khan, {Akbar H.} and David Holmes and Wilson, {Walter R.} and Steckelberg, {James M.} and Baddour, {Larry M.}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "1011--1015",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Infectious complications of percutaneous vascular closure devices

AU - Sohail, Muhammad R.

AU - Khan, Akbar H.

AU - Holmes, David

AU - Wilson, Walter R.

AU - Steckelberg, James M.

AU - Baddour, Larry M.

PY - 2005

Y1 - 2005

N2 - OBJECTIVE: To describe the infectious complications of percutaneous vascular closure devices (PVCDs) on the basis of our institutional experience with PVCDs and the published medical literature. PATIENTS AND METHODS: We retrospectively reviewed all cases of PVCD-related Infection seen at the Mayo Clinic in Rochester, Mlnn, between January 1, 2000, and December 31, 2003, and searched the English language medical literature for all previously published reports. RESULTS: We identified 46 cases in the medical literature and 6 cases from our institutional database. The median age of patients was 63 years (range, 40-79 years). Diabetes mellitus and obesity were the most common comorbidlties. The median incubation period from device insertion to presentation with access-site infection was 8 days (range, 2-29 days). The most common presenting symptoms were pain, erythema, fever, swelling, and purulent drainage at the access site. Mycotic pseudoaneurysm (22 cases) was the most common complication. Staphylococcus aureus was responsible for most (75%) of the Infections. All patients underwent surgical débrldement, and 54% required reconstructive procedures. The median duration of antibiotic treatment was 28 days (range, 7-42 days). The mortality rate was 6% (3 patients). CONCLUSIONS: Infection associated with PVCD placement is uncommon but is an extremely serious complication. Morbidity is high, and aggressive medical and surgical interventions are required to achieve cure.

AB - OBJECTIVE: To describe the infectious complications of percutaneous vascular closure devices (PVCDs) on the basis of our institutional experience with PVCDs and the published medical literature. PATIENTS AND METHODS: We retrospectively reviewed all cases of PVCD-related Infection seen at the Mayo Clinic in Rochester, Mlnn, between January 1, 2000, and December 31, 2003, and searched the English language medical literature for all previously published reports. RESULTS: We identified 46 cases in the medical literature and 6 cases from our institutional database. The median age of patients was 63 years (range, 40-79 years). Diabetes mellitus and obesity were the most common comorbidlties. The median incubation period from device insertion to presentation with access-site infection was 8 days (range, 2-29 days). The most common presenting symptoms were pain, erythema, fever, swelling, and purulent drainage at the access site. Mycotic pseudoaneurysm (22 cases) was the most common complication. Staphylococcus aureus was responsible for most (75%) of the Infections. All patients underwent surgical débrldement, and 54% required reconstructive procedures. The median duration of antibiotic treatment was 28 days (range, 7-42 days). The mortality rate was 6% (3 patients). CONCLUSIONS: Infection associated with PVCD placement is uncommon but is an extremely serious complication. Morbidity is high, and aggressive medical and surgical interventions are required to achieve cure.

UR - http://www.scopus.com/inward/record.url?scp=23244444498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244444498&partnerID=8YFLogxK

M3 - Article

C2 - 16092579

AN - SCOPUS:23244444498

VL - 80

SP - 1011

EP - 1015

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -